<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01053052</url>
  </required_header>
  <id_info>
    <org_study_id>Femasys 300-001</org_study_id>
    <nct_id>NCT01053052</nct_id>
  </id_info>
  <brief_title>Study of FemVue(TM) Sono Tubal Evaluation System Method Comparison to HSG</brief_title>
  <official_title>A Comparative Study of Methods for Tubal Patency Determination and Uterine Cavity Evaluation: Sonography With the FemVue(TM) Catheter System vs. Hysterosalpingography (HSG)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Femasys Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Femasys Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multi-center prospective comparison of fallopian tubal patency determination and uterine
      evaluation interventions using legally marketed devices for their intended purposes, and
      using each subject as their own control.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study cancelled prior to recruitment.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Study cancelled without recruitment
  </why_stopped>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Concordance of evaluations of fallopian tube patency and intrauterine pathology.</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>subject discomfort assessment</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Fallopian Tube Patency Tests</condition>
  <arm_group>
    <arm_group_label>Sonography with FemVue vs. HSG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>FemVue sonography and HSG</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sonography with FemVue, and HSG</intervention_name>
    <description>Sono HSG for FDA 510(k) cleared indication for use</description>
    <arm_group_label>Sonography with FemVue vs. HSG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Non-pregnant women between the ages of 18 and 45 who desire to know the patency status of
        the fallopian tubes and if the uterine cavity is free of pathology who have:

          -  Been attempting conception for 6 months or

          -  A history of PID (including the conditions listed below) or

               -  Chlamydia

               -  Gonorrhea

               -  Endometriosis

          -  A history of pelvic surgery or

          -  Advanced maternal age (â‰¥ 35) And

          -  Negative test for Gonorrhea/Chlamydia or prophylactic antibiotic treatment

          -  Without current bi-lateral tubal sterilization

          -  Signed Informed Consent

        Exclusion Criteria:

        Uterine anomaly or lesion(s) preventing catheter placement for either the FemVue or HSG
        procedure(as identified and documented by TVUS Screening procedure or the uterine cavity
        evaluation during the FemVue procedure or any previous diagnostic procedure)

          -  obstructing access to uterine cornu

          -  distorting fundus at the midline region
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 18, 2010</study_first_submitted>
  <study_first_submitted_qc>January 20, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2010</study_first_posted>
  <last_update_submitted>May 8, 2017</last_update_submitted>
  <last_update_submitted_qc>May 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Patency Tests, Fallopian Tubes</keyword>
  <keyword>Hysterosalpingography</keyword>
  <keyword>Sonography, Medical</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

